Issues Related to the Development of Drugs for the Treatment of Patients with Vascular Dementia (VaD)

3/16/01


Click here to start


Table of Contents

Issues Related to the Development of Drugs for the Treatment of Patients with Vascular Dementia (VaD)

Is VaD Clearly Definable Clinically?

Is VaD Clearly Definable Clinically?

Is VaD Clearly Definable Clinically?

Is VaD Clearly Definable Clinically?

Is VaD Clearly Definable Clinically?

Is VaD distinguishable from AD?

Is VaD distinguishable from AD?

Is VaD distinguishable from AD?

Outcome Measures in the Design of VaD Clinical Drug Trials

Other Features in the Design of VaD Clinical Drug Trials

Conclusions

Conclusions

Conclusions